Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma.
Klümper N, Sikic D, Saal J, Büttner T, Goldschmidt F, Jarczyk J, Becker P, Zeuschner P, Weinke M, Kalogirou C, Breyer J, Burger M, Nuhn P, Tully K, Roghmann F, Bolenz C, Zengerling F, Wirtz RM, Muders M, Kristiansen G, Bald T, Ellinger J, Wullich B, Hölzel M, Hartmann A, Erben P, Ritter M, Eckstein M. Klümper N, et al. Among authors: ellinger j. Eur J Cancer. 2022 May;167:13-22. doi: 10.1016/j.ejca.2022.02.022. Epub 2022 Mar 30. Eur J Cancer. 2022. PMID: 35366569 Free article.
DNA hypermethylation in papillary renal cell carcinoma.
Ellinger J, Holl D, Nuhn P, Kahl P, Haseke N, Staehler M, Siegert S, Hauser S, Stief CG, Müller SC, Bastian PJ. Ellinger J, et al. BJU Int. 2011 Feb;107(4):664-9. doi: 10.1111/j.1464-410X.2010.09468.x. BJU Int. 2011. PMID: 20553257
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ. May M, et al. Among authors: ellinger j. Ann Surg Oncol. 2011 Jul;18(7):2018-25. doi: 10.1245/s10434-010-1538-6. Epub 2011 Jan 19. Ann Surg Oncol. 2011. PMID: 21246405
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ. May M, et al. Among authors: ellinger j. Eur Urol. 2011 May;59(5):712-8. doi: 10.1016/j.eururo.2011.01.030. Epub 2011 Jan 28. Eur Urol. 2011. PMID: 21296488
Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM. May M, et al. Among authors: ellinger j. Scand J Urol Nephrol. 2011 Sep;45(4):251-7. doi: 10.3109/00365599.2011.562235. Epub 2011 Mar 10. Scand J Urol Nephrol. 2011. PMID: 21388337
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Fritsche HM. May M, et al. Among authors: ellinger j. BJU Int. 2011 Oct;108(8 Pt 2):E278-83. doi: 10.1111/j.1464-410X.2011.10189.x. Epub 2011 Jun 23. BJU Int. 2011. PMID: 21699644
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. May M, et al. Among authors: ellinger j. Urol Oncol. 2013 Oct;31(7):1141-7. doi: 10.1016/j.urolonc.2011.09.011. Epub 2011 Nov 6. Urol Oncol. 2013. PMID: 22056404
External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.
May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. May M, et al. Among authors: ellinger j. J Urol. 2012 Apr;187(4):1210-4. doi: 10.1016/j.juro.2011.11.104. Epub 2012 Feb 14. J Urol. 2012. PMID: 22335861
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ. Nuhn P, et al. Among authors: ellinger j. Eur J Surg Oncol. 2012 Jul;38(7):637-42. doi: 10.1016/j.ejso.2012.02.187. Epub 2012 Mar 27. Eur J Surg Oncol. 2012. PMID: 22459902
276 results